Just remember that our resident ‘thinker’ @bid said yesterday that Starpharma should hold off on doing a DEP deal until the share price gets up from these record lows.
With this type of counter-intuitive thinking and elite-level strategy, I reckon I know a company that would welcome you with open arms onto their board of directors! Although, you may have to be an ex-CSL employee to qualify.
Ann: DEP irinotecan clinical data presented at AACR meeting, page-15
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
